Ertugliflozin, an essential component of Loncom Pharma's Endocrine APIS, plays a pivotal role in managing diabetes. It helps regulate blood sugar levels, providing an improved quality of life for diabetic individuals.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
